Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis

被引:18
|
作者
Wei, Xuejiao [1 ]
Hou, Yue [1 ]
Long, Mengtuan [1 ]
Jiang, Lili [2 ]
Du, Yujun [1 ]
机构
[1] First Hosp Jilin Univ, Dept Nephrol, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Phys, Examinat Ctr, Changchun, Peoples R China
来源
关键词
hypoxia-inducible factor-1 alpha; aerobic glycolysis; oxidative phosphorylation; metabolic reprogramming; renal fibrosis; PYRUVATE-KINASE M2; NF-KAPPA-B; TNF-ALPHA; TRANSCRIPTIONAL REGULATION; MESENCHYMAL TRANSITION; PROMOTES FIBROGENESIS; AEROBIC GLYCOLYSIS; KIDNEY-DISEASE; GROWTH-FACTOR; UP-REGULATION;
D O I
10.3389/fendo.2022.927329
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Renal fibrosis is the result of renal tissue damage and repair response disorders. If fibrosis is not effectively blocked, it causes loss of renal function, leading to chronic renal failure. Metabolic reprogramming, which promotes cell proliferation by regulating cellular energy metabolism, is considered a unique tumor cell marker. The transition from oxidative phosphorylation to aerobic glycolysis is a major feature of renal fibrosis. Hypoxia-inducible factor-1 alpha (HIF-1 alpha), a vital transcription factor, senses oxygen status, induces adaptive changes in cell metabolism, and plays an important role in renal fibrosis and glucose metabolism. This review focuses on the regulation of proteins related to aerobic glycolysis by HIF-1 alpha and attempts to elucidate the possible regulatory mechanism underlying the effects of HIF-1 alpha on glucose metabolism during renal fibrosis, aiming to provide new ideas for targeted metabolic pathway intervention in renal fibrosis.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Role of macrophage hypoxia-inducible factor-1 in the development of renal fibrosis in mice
    Tateishi, Yu
    Oka, Mayuko
    Shiota, Masayuki
    Izumi, Yasukatsu
    Miura, Katsuyuki
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 89P - 89P
  • [2] Role Hypoxia-inducible Factor-1α in the Development of Liver Fibrosis
    Copple, Bryan L.
    Moon, Jeon-Ok
    [J]. FASEB JOURNAL, 2008, 22
  • [3] Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment
    Seo, Jieun
    Yun, Jeong-Eun
    Kim, Sung Joon
    Chun, Yang-Sook
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2022, 474 (06): : 591 - 601
  • [4] Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment
    Jieun Seo
    Jeong-Eun Yun
    Sung Joon Kim
    Yang-Sook Chun
    [J]. Pflügers Archiv - European Journal of Physiology, 2022, 474 : 591 - 601
  • [5] The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
    Liu, Huixia
    Li, Yujuan
    Xiong, Jing
    [J]. MOLECULES, 2022, 27 (21):
  • [6] Activation of hypoxia-inducible factor-1 in bacillary angiomatosis -: Evidence for a role of hypoxia-inducible factor-1 in bacterial infections
    Kempf, VAJ
    Lebiedziejewski, M
    Alitalo, K
    Wälzlein, JH
    Ehehalt, U
    Fiebig, J
    Huber, S
    Schütt, B
    Sander, CA
    Müller, S
    Grassl, G
    Yazdi, AS
    Brehm, B
    Autenrieth, IB
    [J]. CIRCULATION, 2005, 111 (08) : 1054 - 1062
  • [7] Susceptibility of renal fibrosis in diabetes: Role of hypoxia inducible factor-1
    Mei, Shuqin
    Li, Lin
    Zhou, Xiangjun
    Xue, Cheng
    Livingston, Man J.
    Wei, Qingqing
    Dai, Bing
    Mao, Zhiguo
    Mei, Changlin
    Dong, Zheng
    [J]. FASEB JOURNAL, 2022, 36 (08):
  • [8] Regulation of Wound Healing and Fibrosis by Hypoxia and Hypoxia-Inducible Factor-1
    Ruthenborg, Robin J.
    Ban, Jae-Jun
    Wazir, Anum
    Takeda, Norihiko
    Kim, Jung-whan
    [J]. MOLECULES AND CELLS, 2014, 37 (09) : 637 - 643
  • [9] The Role of Hypoxia-Inducible Factor-1α in Response to Injury and Hypoxia
    Baldea, Anthony J.
    Luchette, Fred A.
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (10) : 2312 - 2313
  • [10] The Role of Hypoxia-inducible Factor-1 in Bladder Cancer
    Chai, Jiagui
    Yin, Sifan
    Feng, Wenbo
    Zhang, Tao
    Ke, Changxing
    [J]. CURRENT MOLECULAR MEDICINE, 2024, 24 (07) : 827 - 834